44 related articles for article (PubMed ID: 24045921)
1. Projecting the yearly mortality reductions due to a cancer screening programme.
Liu ZA; Hanley JA; Strumpf EC
J Med Screen; 2013; 20(3):157-64. PubMed ID: 24045921
[TBL] [Abstract][Full Text] [Related]
2. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
3. Measuring mortality reductions in cancer screening trials.
Hanley JA
Epidemiol Rev; 2011; 33():36-45. PubMed ID: 21624962
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.
Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Suzuki T; Yamanda T; Kondo R; Hanaoka T; Takayama F; Kubo K; Fushimi H
Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180
[TBL] [Abstract][Full Text] [Related]
7. Annual number of lung cancer deaths potentially avertable by screening in the United States.
Ma J; Ward EM; Smith R; Jemal A
Cancer; 2013 Apr; 119(7):1381-5. PubMed ID: 23440730
[TBL] [Abstract][Full Text] [Related]
8. Cancer screening in the USA.
Smith RA
J Med Screen; 2006; 13 Suppl 1():S48-53. PubMed ID: 17227643
[TBL] [Abstract][Full Text] [Related]
9. The effect of service screening on breast cancer mortality rates.
Cox B
Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
[TBL] [Abstract][Full Text] [Related]
10. Cancer screening: evidence and practice in Europe 2008.
Hakama M; Coleman MP; Alexe DM; Auvinen A
Eur J Cancer; 2008 Jul; 44(10):1404-13. PubMed ID: 18343653
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of cancer screening from the epidemiologic point of view].
Oshima A
Gan No Rinsho; 1989 Jan; 35(2):253-7. PubMed ID: 2649707
[TBL] [Abstract][Full Text] [Related]
12. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions?
Wang PE; Wang TT; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S54-8. PubMed ID: 17227644
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the effectiveness of radon screening programs in reducing lung cancer mortality.
Gagnon F; Courchesne M; Lévesque B; Ayotte P; Leclerc JM; Belles-Isles JC; Prévost C; Dessau JC
Risk Anal; 2008 Oct; 28(5):1221-30. PubMed ID: 18761730
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of cancer in the United States.
Cresanta JL
Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
[TBL] [Abstract][Full Text] [Related]
15. Significance tests for cancer screening trials.
Tarone RE; Gart JJ
Biometrics; 1989 Sep; 45(3):883-90. PubMed ID: 2790126
[TBL] [Abstract][Full Text] [Related]
16. Early reporting for cancer screening trials.
Baker SG; Kramer BS; Prorok PC
J Med Screen; 2008; 15(3):122-9. PubMed ID: 18927094
[TBL] [Abstract][Full Text] [Related]
17. Screening for lung cancer.
Eddy DM
Ann Intern Med; 1990 Jan; 112(1):73-4. PubMed ID: 2403475
[No Abstract] [Full Text] [Related]
18. Deaths averted: An unbiased alternative to rate ratios for measuring the performance of cancer screening programs.
Deck W; Hanley JA
J Med Screen; 2023 Nov; ():9691413231215963. PubMed ID: 37990538
[TBL] [Abstract][Full Text] [Related]
19. Estimating reductions in cancer mortality.
J Natl Cancer Inst; 2003 Oct; 95(20):1501. PubMed ID: 14559862
[No Abstract] [Full Text] [Related]
20. Should we expect all-cause mortality reductions in large screening studies?
Dobbin KK; Ebell M
Br J Gen Pract; 2018 Jun; 68(671):290-291. PubMed ID: 29853594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
